ClinicalMetric / Countries / Hungary / hepatic insufficiency
← 🇭🇺 Hungary Trials
🇭🇺 Hungary Country × Condition

hepatic insufficiency Clinical Trials in Hungary

Active clinical trials for hepatic insufficiency with research sites in Hungary. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇭🇺 Hungary

Active Trials in Hungary (2)

NCT07401862 Phase 1
Recruiting

A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Enrollment
36 pts
Country
🇭🇺 Hungary
Eli Lilly and Company
View Trial →
NCT07165002 Phase 1
Recruiting

A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

Enrollment
32 pts
Country
🇭🇺 Hungary
Eli Lilly and Company
View Trial →

Frequently Asked Questions

How many hepatic insufficiency clinical trials are active in Hungary?
There are currently 2 active clinical trials for hepatic insufficiency with sites in Hungary, of which 2 are actively recruiting patients.
How can I join a hepatic insufficiency clinical trial in Hungary?
To join a hepatic insufficiency clinical trial in Hungary, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Hungary directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hepatic insufficiency trials in Hungary?
Active hepatic insufficiency trials in Hungary span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Hungary Trials → Global hepatic insufficiency Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology